Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Cash from Financing Activities (2021 - 2025)

Cardio Diagnostics Holdings' Cash from Financing Activities history spans 5 years, with the latest figure at $39955.0 for Q3 2025.

  • For Q3 2025, Cash from Financing Activities fell 97.91% year-over-year to $39955.0; the TTM value through Sep 2025 reached $10.5 million, up 131.03%, while the annual FY2024 figure was $11.9 million, 228.74% up from the prior year.
  • Cash from Financing Activities for Q3 2025 was $39955.0 at Cardio Diagnostics Holdings, up from -$115037.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $65.8 million in Q4 2021 and bottomed at -$1.7 million in Q4 2022.
  • The 5-year median for Cash from Financing Activities is $1.0 million (2022), against an average of $5.5 million.
  • The largest annual shift saw Cash from Financing Activities surged 28415.99% in 2022 before it tumbled 127.73% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $65.8 million in 2021, then tumbled by 102.62% to -$1.7 million in 2022, then soared by 94.58% to -$93500.0 in 2023, then soared by 7898.72% to $7.3 million in 2024, then crashed by 99.45% to $39955.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Cash from Financing Activities are $39955.0 (Q3 2025), -$115037.0 (Q2 2025), and $3.3 million (Q1 2025).